caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1760431845

Eugene WyszynskiDO

PRACTICEDR WYSZ PLLCSee all providers at this practice →
Hematology-OncologyFarmers Branch, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
64.1
Quality
29.6
Cost
17.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
-1.30%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$415
Payment records
9
By payment type
Food and Beverage$315
Education$100
Top paying entities
Food and Beverage$315
Education$100
REFERRAL NETWORK

Where Eugene Wyszynski's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS59661
Health Imaging Partners, Llc
Independent Diagnostic Testing Facility (IDTF) · Plano, TX
47221
Terence Casey
Pathology · New Orleans, LA
41118
Pathgroup Labs, Llc
Clinical Laboratory · Nashville, TN
41173
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
2790
John Kim
Diagnostic Radiology · Seattle, WA
21177
Anita Tharian
Hematology-Oncology · Mesquite, TX
17166
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
764
Unique beneficiaries
—
Total services
3,709
Distinct HCPCS
16
Medicare payment
$149K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — above median (cohort median 2,625).
PRESCRIBING · PART D · 2024
Total Rx claims
158
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
10
Brand share
62.0%
Top prescribed drugs
Ruxolitinib Phosphate22 claims
Letrozole21 claims
Immun Globg(Igg)/Malt/Iga Ov5018 claims
Pembrolizumab17 claims
Alectinib Hcl15 claims